Ophthalmology concept experiences a volatile rebound, TMSP hits the limit up
The ophthalmology concept experienced a volatile rebound, with TMSP hitting the limit up, followed by gains in Xingqi Pharmaceutical, Laimei Pharmaceutical, Nostrand, Daheng Technology, Guanhao Biological, and Doctor Glasses
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments